There are 119 resources available
11P - Novel HDAC6 inhibitors show anti-lymphoma activity alone and in combination with venetoclax and copanlisib
Presenter: Afua Mensah
Session: e-Poster Display session
4P - Antitumor efficacy of integrin _V_3 Antibody conjugated ZnO Nanocarrier based Drug Delivery System to target Breast carcinoma
Presenter: Karuppaiya Vimala
Session: e-Poster Display session
12P - Circulating tumor DNA as early marker of response to treatment in stage IV gastrointestinal cancer
Presenter: Patrick Kirchweger
Session: e-Poster Display session
13P - Transcriptional Profiling of FET-rearranged sarcomas in response to SP-2577
Presenter: Galen Rask
Session: e-Poster Display session
14P - A novel small molecule METTL3 inhibitor exerts promising antitumor effects on oral squamous cell carcinoma
Presenter: Paramasivam Arumugam
Session: e-Poster Display session
53P - Assessing the reporting quality of early phase dose-finding trials
Presenter: Christina Yap
Session: e-Poster Display session
45P - Alofanib in subsequent therapy of advanced gastric cancer: Final results from the phase Ib clinical trial
Presenter: Liubov Vladimirova
Session: e-Poster Display session
Resources:
Abstract
55P - Potential benefits of extensive genomic analysis in patients with KRAS mutated solid tumors; concurrent alterations and potential targets
Presenter: Ida Jacobsen
Session: e-Poster Display session
52P - Novel inhibitors of androgen receptor with antiproliferative potency against hormone-sensitive and hormone-resistant breast cancer cells
Presenter: Alexander Scherbakov
Session: e-Poster Display session
54P - Targeted treatment options for childhood hepatoblastoma using high-throughput drug screening
Presenter: Ruth Nousiainen
Session: e-Poster Display session